Alphabet Inc. Verve Therapeutics, Inc. Transaction History
Alphabet Inc.
- $1.46 Billion
- Q3 2024
A detailed history of Alphabet Inc. transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 12,349,086 shares of VERV stock, worth $77.8 Million. This represents 4.09% of its overall portfolio holdings.
Number of Shares
12,349,086
Previous 12,349,086
-0.0%
Holding current value
$77.8 Million
Previous $60.3 Million
0.82%
% of portfolio
4.09%
Previous 3.79%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
186Shares Held
73.3MCall Options Held
85KPut Options Held
215K-
Black Rock Inc. New York, NY6.62MShares$41.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.96MShares$31.3 Million0.01% of portfolio
-
State Street Corp Boston, MA4.25MShares$26.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$25.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$25.2 Million1.5% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $378M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...